Many commonly used pharmaceutical agents have been found to inhibit bacterial growth in vitro. Determinations of antimicrobial concentrations in sera of patients taking nonrecognized antibacterial agents could possibly be altered if bioassay systems are utilized for the determinations. We therefore attempted to determine the in vitro effect of commonly used drugs on bioassay indicator organisms. Fifty-one different agents (antihistamines, anticholinergics, central nervous, system agents, cardiovascular agents, analgesics, steroids, muscle blockers, and other miscellaneous agents) were tested for inhibition or enhancement of the growth of Bacillus subtilis, Staphylococcus aureus, Micrococcus luteus, and Klebsiella pneumoniae. None of the agents tested exhibited any effect on standard in vitro bioassay organisms. Nortriptyline hydrochloride inhibited the growth of B. subtilis and M. luteus at a concentration of 500 ,ug/ml (zones of inhibition, 14 and 13 mm, respectively), but no inhibition was observed with concentrations of 50 ,g/ml or lower.
Pharmaceutical agents not usually classified as antibacterial agents have been found to inhibit bacterial growth in vitro. Non-antibacterial agents such as promazine (4) , caffeine (3), theophyiline (3) , heparin (10) , and ascorbic acid (9) are reported to possess bacteriostatic or bactericidal properties, often at their usual serum concentrations. Other classes of agents (e.g., cancer chemotherapy drugs [11] , anesthetics [8, 12] , or steroid hormones [6] ) or derivatives of certain classes (e.g., barbituric acids [1, 2] and benzodiazepines [7] ) have demonstrated similar properties.
Since a wide variety of drugs demonstrate in vitro antibacterial activity, other agents in common clinical usage may also possess such activity. Therefore, patients taking nonrecognized antibacterial agents may have serum concentrations sufficient to influence bacterial growth in vitro. A specific concern is that determinations of antimicrobial concentrations in the sera of patients taking nonrecognized antibacterial agents may be altered if bioassay systems are utilized for the determinations.
Our interest originated when intraoperative concentrations of cephalosporins were determined in the sera of patients undergoing surgical procedures. Many such patients receive 10 or more medications in the perioperative period, and it was considered essential to determine the effect of these frequently administered agents on in vitro bioassay systems. To our knowledge, no comprehensive information is available in the literature describing the effect of commonly used non-antibacterial agents on in vitro bioassay systems.
MATERIALS AND METHODS Agents tested.
A list of the agents tested is given in Table 1 . Each of the agents was obtained from the pharmaceutical manufacturers as pure powder with no preservatives or other additives. For each agent a solution was prepared with a final concentration of 4.16 mg/ml. The agents were dissolved in distilled water or, if necessary, 95% ethanol or dilute sodium hydroxide. From each of these solutions, 0.3 ml was removed and mixed individually with 2.2 ml of serum from normal volunteers, resulting in a final drug concentration of 500 ,g/ml. The solutions were mixed by vortexing and then frozen (-20°C) until analysis. For this screening of assay interference, concentrations much greater than those usually achieved in vivo were desired. Each of the solutions was then tested in the manner described below.
Bioassay. Bacillus subtilis ATCC 6633 spore suspensions were obtained from Difco Laboratories; Staphylococcus aureus ATCC 6538P, Micrococcus luteus ATCC 9341, and a multiply resistant strain of Klebsiella pneumoniae (ATCC 27799) were lyophilized preparations from the American Type Culture Collection. Assay plates were prepared the day of use with Difco antibiotic medium no. 1 (S. aureus), no. 5 (B. subtilis), or no. 11 (M. luteus and K. pneumoniae) as described previously (5). Plastic petri dishes (100 by 15 mm; Falcon Plastics) were used with agar volumes of 5 or 10 ml (B. subtilis) or 9 ml (S. aureus, M. luteus, and K. Despite the large number of reports of the antimicrobial activity of nonrecognized antibacterial agents the agents that we examined failed to show significant influence on bioassay indicator organisms.
